What is the address of DR. LIEVE VAN CASTEREN, CARDIOLOOG?

The registered office of DR. LIEVE VAN CASTEREN, CARDIOLOOG is located at Elisabethlaan 12, 3200 Aarschot.

Is DR. LIEVE VAN CASTEREN, CARDIOLOOG still active?

Yes. According to the CBE (30 September 2026) DR. LIEVE VAN CASTEREN, CARDIOLOOG is active, legal situation “Normale toestand”, started on 9 December 2021.

Is DR. LIEVE VAN CASTEREN, CARDIOLOOG registered on Peppol?

Yes, DR. LIEVE VAN CASTEREN, CARDIOLOOG is registered on the Peppol network with ID 0208:0778408172.

What is the enterprise number of DR. LIEVE VAN CASTEREN, CARDIOLOOG?

The enterprise number of DR. LIEVE VAN CASTEREN, CARDIOLOOG is BE0778408172.

When was DR. LIEVE VAN CASTEREN, CARDIOLOOG founded?

DR. LIEVE VAN CASTEREN, CARDIOLOOG was founded on 9 December 2021.

Who are the directors of DR. LIEVE VAN CASTEREN, CARDIOLOOG?

According to the 2025 annual accounts, the directors of DR. LIEVE VAN CASTEREN, CARDIOLOOG are: Lieve Van Casteren.

Is DR. LIEVE VAN CASTEREN, CARDIOLOOG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. LIEVE VAN CASTEREN, CARDIOLOOG make in 2025?

DR. LIEVE VAN CASTEREN, CARDIOLOOG posted a profit after taxes of € 208,907 in financial year 2025.

What is the revenue of DR. LIEVE VAN CASTEREN, CARDIOLOOG?

As a small company, DR. LIEVE VAN CASTEREN, CARDIOLOOG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 290,659.

DR. LIEVE VAN CASTEREN, CARDIOLOOG (Private Limited)

Dossier DR. LIEVE VAN CASTEREN, CARDIOLOOG, printed on 30 September 2026 from databakkes.be/en/0778408172/dr-lieve-van-casteren-cardioloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. LIEVE VAN CASTEREN, CARDIOLOOG from Aarschot, company number BE0778408172, closed financial year 2025 with a result of € 208,907 after tax. For that financial year DR. LIEVE VAN CASTEREN, CARDIOLOOG recorded a gross margin of € 290,659 and equity of € 477,984. Compared with financial year 2024, the result moved from € 157,923 to € 208,907. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Growing

€ 477,984

▲ 20% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 208,907

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 89,433

▼ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,000 paid out

62 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 6,502

▼ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 819

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 28,187

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 203,831 Gross margin 2022: € 203,831 First fiscal year in the series	€ 129,556 Gross margin 2023: € 129,556 ▼ 36% vs 2022 (€ 203,831) Unfavourable step	€ 224,809 Gross margin 2024: € 224,809 ▲ 74% vs 2023 (€ 129,556) Favourable step	€ 290,659 Gross margin 2025: € 290,659 ▲ 29% vs 2024 (€ 224,809) Favourable step	▲ 29%
Profit after taxes	€ 134,743 Profit after taxes 2022: € 134,743 First fiscal year in the series	€ 82,411 Profit after taxes 2023: € 82,411 ▼ 39% vs 2022 (€ 134,743) Unfavourable step	€ 157,923 Profit after taxes 2024: € 157,923 ▲ 92% vs 2023 (€ 82,411) Favourable step	€ 208,907 Profit after taxes 2025: € 208,907 ▲ 32% vs 2024 (€ 157,923) Favourable step	▲ 32%
Equity	€ 158,743 Equity 2022: € 158,743 First fiscal year in the series	€ 241,154 Equity 2023: € 241,154 ▲ 52% vs 2022 (€ 158,743) Favourable step	€ 399,077 Equity 2024: € 399,077 ▲ 65% vs 2023 (€ 241,154) Favourable step	€ 477,984 Equity 2025: € 477,984 ▲ 20% vs 2024 (€ 399,077) Favourable step	▲ 20%
Total debts	€ 230,100 Total debts 2022: € 230,100 First fiscal year in the series	€ 220,349 Total debts 2023: € 220,349 ▼ 4% vs 2022 (€ 230,100) Favourable step	€ 9,407 Total debts 2024: € 9,407 ▼ 96% vs 2023 (€ 220,349) Favourable step	€ 139,506 Total debts 2025: € 139,506 ▲ € 130,099 vs 2024 (€ 9,407) Unfavourable step	▲ € 130,099
Cash	€ 86,653 Cash 2022: € 86,653 First fiscal year in the series	€ 128,366 Cash 2023: € 128,366 ▲ 48% vs 2022 (€ 86,653) Favourable step	€ 133,518 Cash 2024: € 133,518 ▲ 4% vs 2023 (€ 128,366) Favourable step	€ 89,433 Cash 2025: € 89,433 ▼ 33% vs 2024 (€ 133,518) Unfavourable step	▼ 33%
Retained profit	€ 134,743 Retained profit 2022: € 134,743 First fiscal year in the series	€ 217,154 Retained profit 2023: € 217,154 ▲ 61% vs 2022 (€ 134,743) Favourable step	€ 375,077 Retained profit 2024: € 375,077 ▲ 73% vs 2023 (€ 217,154) Favourable step	€ 453,984 Retained profit 2025: € 453,984 ▲ 21% vs 2024 (€ 375,077) Favourable step	▲ 21%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 130,000 Dividend 2025: € 130,000 Unchanged (€ 0) Unchanged
Balance sheet total	€ 388,843 Balance sheet total 2022: € 388,843 First fiscal year in the series	€ 461,503 Balance sheet total 2023: € 461,503 ▲ 19% vs 2022 (€ 388,843) Unchanged	€ 408,483 Balance sheet total 2024: € 408,483 ▼ 11% vs 2023 (€ 461,503) Unchanged	€ 617,490 Balance sheet total 2025: € 617,490 ▲ 51% vs 2024 (€ 408,483) Unchanged	▲ 51%

Key figures of DR. LIEVE VAN CASTEREN, CARDIOLOOG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LIEVE VAN CASTEREN, CARDIOLOOG?

What happened at DR. LIEVE VAN CASTEREN, CARDIOLOOG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 208,907 (▲ 32% vs 2024). Source: NBB ↗
Dec 9, 2021 New establishment in Aarschot. KBO
Dec 9, 2021 Start of the company according to the CBE. KBO
2021 Lieve Van Casteren became a director. NBB

In short

From € 134,743 profit in 2022 to € 208,907 profit in 2025.

Paid € 179,934 in corporate taxes since 2022.

Best year ever: 2025, with € 208,907 profit.

Paid out € 130,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LIEVE VAN CASTEREN, CARDIOLOOG? We notify you, reason included.

Follow DR. LIEVE VAN CASTEREN, CARDIOLOOG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Lieve Van Casteren

DR. LIEVE VAN CASTEREN, CARDIOLOOG

Behind DR. LIEVE VAN CASTEREN, CARDIOLOOG is Lieve Van Casteren.

See the full network in the app

Directors

According to the 2025 annual accounts

Lieve Van Casteren

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Elisabethlaan 12

3200 Aarschot

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0778.408.172
VAT number: BE 0778.408.172
Registered office: Elisabethlaan 12, 3200 Aarschot
Names & denominations: DR. LIEVE VAN CASTEREN, CARDIOLOOG
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 9 December 2021
Peppol: Active · Active since 5 Sept 2025

View on CBE Public ↗ Annual accounts (NBB) ↗